Credit Suisse’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12,449
| Closed | -$49K | – | 3135 |
|
|
2023
Q3 | $49K | Sell |
12,449
-1,062
| -8% | -$4.18K | ﹤0.01% | 3108 |
|
|
2023
Q2 | $144K | Buy |
+13,511
| New | +$144K | ﹤0.01% | 3104 |
|
|
2023
Q1 | – | Sell |
-9,859
| Closed | -$91K | – | 3655 |
|
|
2022
Q4 | $91K | Buy |
9,859
+20
| +0.2% | +$185 | ﹤0.01% | 3332 |
|
|
2022
Q3 | $126K | Buy |
9,839
+109
| +1% | +$1.4K | ﹤0.01% | 3370 |
|
|
2022
Q2 | $129K | Buy |
+9,730
| New | +$129K | ﹤0.01% | 3454 |
|
|
2021
Q2 | – | Sell |
-6,151
| Closed | -$238K | – | 3649 |
|
|
2021
Q1 | $238K | Sell |
6,151
-7,014
| -53% | -$271K | ﹤0.01% | 3229 |
|
|
2020
Q4 | $815K | Buy |
13,165
+5,884
| +81% | +$364K | ﹤0.01% | 2697 |
|
|
2020
Q3 | $243K | Buy |
+7,281
| New | +$243K | ﹤0.01% | 3020 |
|